Blood Cell Biomarker May Predict Anthracycline LV Dysfunction
Monitoring of neutrophil-to-lymphocyte ratio could potentially help risk-stratify women on anthracycline chemotherapy for associated left-ventricular dysfunction, a prospective study suggests.
First Look
source https://www.medscape.com/viewarticle/975632?src=rss
First Look
source https://www.medscape.com/viewarticle/975632?src=rss
Comments
Post a Comment